UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2021
Accession Number:
Submission Type:
CIK: 0001533743
Company Name: Processa Pharmaceuticals, Inc.
File Number: 333-257558